Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.130
+0.070 (2.29%)
Apr 13, 2026, 1:56 PM EDT - Market open

UPC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
22631254
Market Cap Growth
-4.49%-62.31%82.28%-71.97%-77.13%-
Enterprise Value
-22.57-26,440-21,4973.64-2.6436.25
Last Close Price
3.134.20146.40570.002034.008892.00
PE Ratio
--0.52-0.23-0.52-1.554.14
PS Ratio
0.100.000.000.000.311.12
PB Ratio
0.030.000.000.120.260.91
P/TBV Ratio
0000.120.270.80
P/FCF Ratio
-0.000.000.00-8.81-3.45
P/OCF Ratio
-0.000.000.00-9.44-26.13
EV/Sales Ratio
--1.48-0.930.00-0.070.76
EV/EBITDA Ratio
-11.022.850.000.412.58
EV/EBIT Ratio
-9.072.680.000.382.67
EV/FCF Ratio
-4.972.200.001.89-2.33
Debt / Equity Ratio
0.130.130.180.200.080.07
Debt / EBITDA Ratio
-3.86-3.86-1.060.00-0.610.31
Debt / FCF Ratio
-1.74-1.74-0.820.01-2.82-0.28
Net Debt / Equity Ratio
-0.43-0.43-0.470.01-0.32-0.30
Net Debt / EBITDA Ratio
10.1510.152.8502.30-1.24
Net Debt / FCF Ratio
4.584.582.21010.701.12
Asset Turnover
0.510.260.68638.110.620.97
Inventory Turnover
10.525.8819.487925.977.8210.37
Quick Ratio
3.713.712.37140.802.603.36
Current Ratio
4.074.072.541.843.174.50
Return on Equity (ROE)
-13.07%-7.23%-33.01%-5573.90%-11.92%40.22%
Return on Assets (ROA)
-8.41%-4.25%-21.83%-3753.89%-9.58%32.21%
Return on Invested Capital (ROIC)
-17.83%-10.06%-58.67%-6368.94%-17.02%58.09%
Return on Capital Employed (ROCE)
-10.38%-5.62%-33.65%-10659.80%-13.32%34.09%
Earnings Yield
-208.26%-191.91%-428.25%-191.09%-64.36%24.16%
FCF Yield
-301.66%-224812.00%-155353.00%31144.70%-11.35%-29.02%
Buyback Yield / Dilution
-3174.93%-3174.94%-130.39%0.00%-14.60%-18.63%
Total Shareholder Return
-3174.93%-3174.94%-130.39%0.00%-14.60%-18.63%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q